Additional file 1: of Benefits of an expanded use of plasma exchange for anti-neutrophil cytoplasmic antibody-associated vasculitis within a dedicated clinical service
- Neeraj Dhaun (3456026)
- Andrew Saunders (3456020)
- Christopher Bellamy (3456023)
- Rocío Gallardo (3456017)
- Lynn Manson (3456029)
- David Kluth (478331)
Publication date
November 2015
DOIAbstract
Supplementary Methods. Table S1. Comparison of patients receiving rituximab or cyclophosphamide (CYC) for induction. Data are shown as number of patients (%), mean ± standard deviation or median and IQR. Table S2. Comparison of rituximab dosing, cumulative glucocorticoid dose at 3 months, remission, relapse and survival in patients <70 and ≥70 years of age. Data are shown as number of patients (%), mean ± standard deviation or median and IQR. (DOCX 114 kb
Add to ORKG